These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22343491)

  • 1. Cyr61 is a potential prognostic marker for prostate cancer.
    Terada N; Kulkarni P; Getzenberg RH
    Asian J Androl; 2012 May; 14(3):405-8. PubMed ID: 22343491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment.
    D'Antonio KB; Schultz L; Albadine R; Mondul AM; Platz EA; Netto GJ; Getzenberg RH
    Clin Cancer Res; 2010 Dec; 16(23):5908-13. PubMed ID: 21138874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.
    Terada N; Shiraishi T; Zeng Y; Mooney SM; Yeater DB; Mangold LA; Partin AW; Kulkarni P; Getzenberg RH
    Prostate; 2012 Jun; 72(9):966-76. PubMed ID: 22025384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyr61: a potential therapeutic target for prostate cancer.
    Lin CM; Liang CZ
    Asian J Androl; 2014; 16(5):788-9. PubMed ID: 24759589
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis.
    Tang QL; Fan S; Li HG; Chen WL; Shen XM; Yuan XP; Chang SH; Song Y
    Oral Oncol; 2011 May; 47(5):365-70. PubMed ID: 21439895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress.
    Shi J; Huo R; Li N; Li H; Zhai T; Li H; Shen B; Ye J; Fu R; Di W
    BMC Cancer; 2019 Nov; 19(1):1140. PubMed ID: 31766991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma.
    Lin Y; Xu T; Tian G; Cui M
    J Int Med Res; 2014 Apr; 42(2):300-6. PubMed ID: 24595148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
    Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
    PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.
    Wei J; Yu G; Shao G; Sun A; Chen M; Yang W; Lin Q
    Oncotarget; 2016 May; 7(21):31067-78. PubMed ID: 27105510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix associated protein CYR61 is linked to prostate cancer development.
    D'Antonio KB; Toubaji A; Albadine R; Mondul AM; Platz EA; Netto GJ; Getzenberg RH
    J Urol; 2010 Apr; 183(4):1604-10. PubMed ID: 20172544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells.
    Sun ZJ; Wang Y; Cai Z; Chen PP; Tong XJ; Xie D
    Br J Cancer; 2008 Nov; 99(10):1656-67. PubMed ID: 18941464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target.
    Whitaker HC; Warren AY; Eeles R; Kote-Jarai Z; Neal DE
    Prostate; 2010 Feb; 70(3):333-40. PubMed ID: 19790236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer.
    Pilarsky CP; Schmidt U; Eissrich C; Stade J; Froschermaier SE; Haase M; Faller G; Kirchner TW; Wirth MP
    Prostate; 1998 Jul; 36(2):85-91. PubMed ID: 9655260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Bode B; Langsam B; Bertz J; Jentzsch T; Puskas GJ; Born W; Fuchs B
    J Bone Miner Res; 2012 Jan; 27(1):58-67. PubMed ID: 21976359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyr61 Expression Pattern and Association with Clinicopathological Factors in Patients with Cervical Cancer.
    Mayer S; Gabriel B; Erbes T; Timme-Bronsert S; Jäger M; Rücker G; Kuf F; Bouda J; Bartakova A; Hausen AZ; Stickeler E; Gitsch G; Hirschfeld M
    Anticancer Res; 2017 May; 37(5):2451-2456. PubMed ID: 28476813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.
    Zhou ZQ; Cao WH; Xie JJ; Lin J; Shen ZY; Zhang QY; Shen JH; Xu LY; Li EM
    BMC Cancer; 2009 Aug; 9():291. PubMed ID: 19698122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyr61 is up-regulated in prostate cancer and associated with the p53 gene status.
    Lv H; Fan E; Sun S; Ma X; Zhang X; Han DM; Cong YS
    J Cell Biochem; 2009 Mar; 106(4):738-44. PubMed ID: 19180570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
    Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
    Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-based detection of lung cancer using cysteine-rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study.
    Ačkar L; Casjens S; Andreas A; Raiko I; Brüning T; Geffken M; Peine S; Kollmeier J; Johnen G; Bartkowiak K; Weber DG; Pantel K
    Mol Oncol; 2021 Nov; 15(11):2877-2890. PubMed ID: 34510714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells.
    Lee YJ; Lee DM; Lee SH
    Food Chem Toxicol; 2013 Aug; 58():169-76. PubMed ID: 23623839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.